Skip to main content
Premium Trial:

Request an Annual Quote

Bayer CropScience Earmarks Almost $1B in US Investments for 2013 to 2016

NEW YORK (GenomeWeb) – Bayer CropScience today said that it is investing almost $1 billion in capital expenditures in the US between 2013 and 2016 to build up its R&D capabilities and expand its supply of crop protection brands.

The funding is part of a global investment program that Bayer CropScience began last year with total capital expenditures of €2.4 billion ($3.3 billion) between 2013 and 2016.

As part of the new US investments, Bayer CropScience's new integrated R&D site in West Sacramento, Calif., was inaugurated today. The $80 million facility, which will be the headquarters for Bayer CropScience's biologics business, includes a 100,000-square-foot building, a 35,000-square-foot pilot plant to support R&D of biological crop protection products, a 30,000-square-foot vegetable seeds research building, and a 2,000-square-foot greenhouse. The facility has the capacity to house up to 300 employees.

The company said that it has also invested $17 million to expand its Memphis R&D site, bringing the total greenhouse capacity at the facility to 76,000 square feet. Researchers there support Bayer CropScience's global cotton and soybean seed businesses by using molecular breeding and other technologies.

Other investments are targeted at the company's North American and global seeds headquarters in Research Triangle Park, NC; the construction of the Development North America facility dedicated to crop protection and environmental science research; renovations to Bayer CropScience's North American headquarters, scheduled to be completed in 2015; the Cotton Research and Development Laboratory in Lubbock, Texas; and other facilities.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.